Post by Gastric Cancer Foundation

Regulators in Europe approved AstraZeneca’s Imfinzi (durvalumab) in combination with FLOT chemotherapy for the treatment of early-stage gastric cancer, following a key clinical trial that showed a clear survival benefit among patients taking the combination vs. chemotherapy alone. Vis @oncodaily